The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
The past incidence of hepatitis C virus infection: Implications for the future burden of chronic liver disease in the United States
Abstract
Because chronic liver disease may develop many years after acute hepatitis C virus (HCV) infection, the past incidence of acute infections is a major determinant of the future burden of HCV-associated complications. We estimated past incidence of acute HCV infection using national seroprevalence data and relative age-specific incidence data from a sentinel counties surveillance system. Projections of the future prevalence of HCV-infected patients were derived from models that included an 85% drop in HCV infection incidence as observed for reported cases in the early 1990s. The models showed a large increase in the incidence of HCV infections from the late 1960s to the early 1980s. The degree of increase was dependent on the assumed rate of antibody loss; a model with 2.5% annual antibody loss showed annual incidence increasing from 45,000 infections (95% confidence interval [95% CI]: 0-110,000) in the early 1960s to 380,000 infections (95% CI: 250,000 to 500,000) in the 1980s. Projections showed that although the prevalence of HCV infection may be declining currently because of the decline in incidence in the 1990s, the number of persons infected for ≥20 years could increase substantially before peaking in 2015. If the incidence of new HCV infections does not increase in the future, persons born between 1940 and 1965 will be at highest lifetime risk of acquiring the infection.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Prevalence of Hepatitis C Virus Infection in the United States, 1988 through 1994
Alter, M. J., Kruszon-Moran, D., Nainan, O. V., McQuillan, G. M., Gao, F., Moyer, L. A., Kaslow, R. A., & Margolis, H. S. (1999) · New England Journal of Medicine · doi:10.1056/nejm199908193410802 · Cited by 2,992
Self-citationSchaff, Z., & Csmos, G. (1994) · Cited by 1,868
The Natural History of Community-Acquired Hepatitis C in the United States
Alter, M. J., Margolis, H. S., Krawczynski, K., Judson, F. N., Mares, A., Alexander, W. J., Hu, P. Y., Miller, J. K., Gerber, M. A., Sampliner, R. E., et al. (1992) · New England Journal of Medicine · doi:10.1056/nejm199212313272702 · Cited by 1,592
Self-citation[Gastric adenocarcinoma and kidney transplantation].
Barrio, J., García-Bengoechea, M., Emparanza, J. I., & Arenas, J. I. (1998) · PubMed · Cited by 1,132
Alter, M. J. (1997) · Hepatology · doi:10.1002/hep.510260711 · Cited by 1,075
Self-citationApplied regression analysis and other multivariable methods, 3rd ed.
Kleinbaum, D. G., Kupper, L. L., Muller, K. E., & Nizam, A. (1998) · Cited by 871
Hepatitis C: the clinical spectrum of disease.
Hoofnagle, J. H. (1997) · Hepatology · doi:10.1002/hep.510260703 · Cited by 765
Long-Term Mortality after Transfusion-Associated Non-A, Non-B Hepatitis
Seeff, L. B., Buskell-Bales, Z., Wright, E. C., Durako, S. J., Alter, H. J., Iber, F. L., Hollinger, F. B., Gitnick, G., Knodell, R. G., Perrillo, R. P., et al. (1992) · New England Journal of Medicine · doi:10.1056/nejm199212313272703 · Cited by 672
Alter, M. J. (1990) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1990.03450170079026 · Cited by 615
Self-citationLong-term clinical and histopathological follow-up of chronic posttransfusion hepatitis
di Bisceglie, A. M., Goodman, Z. D., Ishak, K. G., Hoofnagle, J. H., Melpolder, J. J., & Alter, H. J. (1991) · Hepatology · doi:10.1002/hep.1840140603 · Cited by 539
Aach, R. D., Stevens, C. E., Hollinger, F. B., Mosley, J. W., Peterson, D. A., Taylor, P. E., Johnson, R. G., Barbosa, L. H., & Nemo, G. J. (1991) · New England Journal of Medicine · doi:10.1056/nejm199111073251901 · Cited by 523
Natural history of hepatitis C
Seeff, L. B. (1997) · Hepatology · doi:10.1002/hep.510260704 · Cited by 409
Applied Regression Analysis and Multivariable Methods
Johnson, R. W., Kleinbaum, D. G., Kupper, L. L., Muller, K. E., & Nizam, A. (1999) · The American Statistician · doi:10.2307/2686116 · Cited by 371
Diagnostic tests for hepatitis C
Gretch, D. R. (1997) · Hepatology · doi:10.1002/hep.510260708 · Cited by 317
Catalytic Models in Epidemiology
Muench, H. (1959) · Harvard University Press eBooks · doi:10.4159/harvard.9780674428928 · Cited by 268
The natural course of chronic hepatitis C
Iwarson, S. (1994) · FEMS Microbiology Reviews · doi:10.1016/0168-6445(94)90033-7 · Cited by 238
THE EFFECT OF UNDERREPORTING ON THE APPARENT INCIDENCE AND EPIDEMIOLOGY OF ACUTE VHIAL HEPATITIS
Alter, M. J., Mares, A., Hadler, S. C., & Maynard, J. E. (1987) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a114496 · Cited by 122
Self-citationLong-term persistence of hepatitis C virus antibodies in a single source outbreak
Dittmann, S., Roggendorf, M., Dürkop, J., Wiese, M., Lorbeer, B., & Deinhardt, F. W. (1991) · Journal of Hepatology · doi:10.1016/0168-8278(91)90076-n · Cited by 113
Antibody to Hepatitis C Virus in Post-Transfusion Hepatitis
Tremolada, F., Casarin, C., TAGGER, A., Ribero, M. L., Realdi, G., Alberti, A., & Ruol, A. (1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-114-4-277 · Cited by 106
Modeling Age- and Time-Specific Incidence from Seroprevalence: Toxoplasmosis
Ades, A. E., & Nokes, D. J. (1993) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a116758 · Cited by 103
The Natural History of Hepatitis C—A Quandary
Seeff, L. B. (1998) · Hepatology · doi:10.1002/hep.510280636 · Cited by 46
Hepatitis C virus antibodies in acute icteric and chronic non-A, non-B hepatitis
McHutchison, J. G., Kuo, G. C., Houghton, M., Choo, Q., & Redeker, A. G. (1991) · Gastroenterology · doi:10.1016/0016-5085(91)90742-4 · Cited by 27
Mortality among injection drug users identified as "out of treatment".
McAnulty, J., Tesselaar, H. M., & Fleming, D. W. (1995) · American Journal of Public Health · doi:10.2105/ajph.85.1.119 · Cited by 22
Cited by
Hepatocellular Carcinoma: Epidemiology and Molecular Carcinogenesis
El–Serag, H. B., & Rudolph, K. L. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.04.061 · Cited by 5,415
Global epidemiology of hepatitis C virus infection
Shepard, C. W., Finelli, L., & Alter, M. J. (2005) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(05)70216-4 · Cited by 2,758
Self-citationMohd Hanafiah, K., Groeger, J., Flaxman, A. D., & Wiersma, S. T. (2013) · Hepatology · doi:10.1002/hep.26141 · Cited by 2,515
The Prevalence of Hepatitis C Virus Infection in the United States, 1999 through 2002
Armstrong, G. L., Wasley, A., Simard, E. P., McQuillan, G. M., Kuhnert, W. L., & Alter, M. J. (2006) · Annals of Internal Medicine · doi:10.7326/0003-4819-144-10-200605160-00004 · Cited by 1,955
Self-citationThe global burden of hepatitis C
Lavanchy, D. (2009) · Liver International · doi:10.1111/j.1478-3231.2008.01934.x · Cited by 1,368
Metadata
- Authors
- Armstrong, G. L., Alter, M. J., McQuillan, G. M., & Margolis, H. S.
- Venue
- Hepatology
- Published
- 2000-03
- Volume
- 31
- Issue
- 3
- Pages
- 777-782
- ISSN
- 0270-9139 (ISSN-L)
- OpenAlex
- W2052402745
- Cited by
- 523
- References
- 23
- FWCI
- 15.48
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.